The PD Frontline study is led by Professor Tony Schapira and his team in the Department of Clinical and Movement Neurosciences, University College London.
Professor Schapira’s research interests include the molecular and clinical aspects of neurodegenerative diseases, with special emphasis on Parkinson’s disease and other movement disorders. He leads an internationally renowned laboratory focused on the understanding and developing treatments for Parkinson’s caused by the GBA gene. Prof. Schapira is also a Consultant Neurologist at the Royal Free Hospital and the National Hospital for Neurology and Neurosurgery.
Consultant Neurologist and Post Doc researcher at the Institute of Neurology, UCL. His research focusses on the genetic background of Parkinson disease. He oversees the genetic analysis for RAPSODI and PD Frontline and coordinates these studies.
Elisa is a member of Professor Schapira’s laboratory. Her principle research interest is the role of the gut-brain axis in Parkinson's disease, especially in people with changes in the GBA gene.
Georgie is a study co-ordinator for PD Frontline and is involved in all aspects of the study's day-to-day management. She plays a leading role in providing genetic counselling and managing study ethics.
Milly is a study co-ordinator for PD Frontline and is involved in all aspects of the study's day-to-day management. She plays a leading role in managing genetic sequencing operations and processing positive samples in the lab.
Jakub is a study co-ordinator for PD Frontline and is involved in all aspects of the study's day-to-day management. He plays a leading role in managing our NHS sites and conducting clinical visits for associated studies.
Finn is a study co-ordinator for PD Frontline and is involved in all aspects of the study's day-to-day management. He plays a leading role in managing social media and conducting bioinformatic analysis of genetic results.
Nadine is the study co-ordinator for RAPSODI and is involved in all aspects of the study's day-to-day management. She is currently completing a PhD investigating the relationship between the GBA1 gene and Parkinson’s disease, and identifying early markers of the condition.